# Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)

> **NCT07719257** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Zhuhai United Laboratories Co., Ltd.** · enrollment: 72 (estimated)

## Conditions studied

- Complicated Urinary Tract Infections(cUTI)

## Interventions

- **DRUG:** TUL108
- **DRUG:** Placebo
- **DRUG:** TUL108

## Key facts

- **NCT ID:** NCT07719257
- **Lead sponsor:** Zhuhai United Laboratories Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719257, "Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07719257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*